Aerovate Therapeutics Inc
NASDAQ:AVTE

Watchlist Manager
Aerovate Therapeutics Inc Logo
Aerovate Therapeutics Inc
NASDAQ:AVTE
Watchlist
Price: 2.63 USD Market Closed
Market Cap: 75.9m USD
Have any thoughts about
Aerovate Therapeutics Inc?
Write Note

Aerovate Therapeutics Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aerovate Therapeutics Inc
Free Cash Flow Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Aerovate Therapeutics Inc
NASDAQ:AVTE
Free Cash Flow
-$56.9m
CAGR 3-Years
-93%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Free Cash Flow
$15.6B
CAGR 3-Years
-10%
CAGR 5-Years
4%
CAGR 10-Years
13%
Gilead Sciences Inc
NASDAQ:GILD
Free Cash Flow
$10B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Free Cash Flow
$6.3B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Free Cash Flow
-$1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-13%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Free Cash Flow
$3.3B
CAGR 3-Years
-15%
CAGR 5-Years
11%
CAGR 10-Years
20%

See Also

What is Aerovate Therapeutics Inc's Free Cash Flow?
Free Cash Flow
-56.9m USD

Based on the financial report for Dec 31, 2023, Aerovate Therapeutics Inc's Free Cash Flow amounts to -56.9m USD.

What is Aerovate Therapeutics Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 3Y
-93%

Over the last year, the Free Cash Flow growth was -45%. The average annual Free Cash Flow growth rates for Aerovate Therapeutics Inc have been -93% over the past three years .

Back to Top